| Primary |
| Constipation |
15.4% |
| Depression |
15.4% |
| Neuropathy Peripheral |
15.4% |
| Product Used For Unknown Indication |
15.4% |
| Asthenia |
7.7% |
| Gastrooesophageal Reflux Disease |
7.7% |
| Hypertension |
7.7% |
| Insomnia |
7.7% |
| Pancreatic Insufficiency |
7.7% |
|
| Pancreatitis |
50.0% |
| Tremor |
50.0% |
|
| Secondary |
| Antiphospholipid Syndrome |
20.0% |
| Gastritis |
20.0% |
| Inflammation |
20.0% |
| Product Used For Unknown Indication |
20.0% |
| Diabetes Mellitus |
10.0% |
| Nasopharyngitis |
10.0% |
|
| Pain |
40.0% |
| Cardiac Arrest |
20.0% |
| Peritonitis |
20.0% |
| Urticaria |
20.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.6% |
| Product Used For Unknown Indication |
17.6% |
| Diffuse Large B-cell Lymphoma |
11.2% |
| Pancreatic Neuroendocrine Tumour |
6.0% |
| Hypertension |
5.9% |
| Diabetes Mellitus |
4.8% |
| Prophylaxis |
3.9% |
| Pain |
3.7% |
| Rash |
3.3% |
| Rhinitis Allergic |
3.0% |
| Asthenopia |
2.6% |
| Pancreatitis Chronic |
2.6% |
| Insomnia |
2.5% |
| Pyrexia |
2.1% |
| Medical Diet |
2.0% |
| Nausea |
2.0% |
| Cystic Fibrosis |
1.9% |
| Breast Cancer |
1.8% |
| Back Pain |
1.7% |
| Coronary Artery Disease |
1.7% |
|
| Pyrexia |
12.4% |
| Febrile Neutropenia |
9.7% |
| Death |
7.1% |
| Subileus |
6.2% |
| Granulocytopenia |
5.3% |
| Rash |
5.3% |
| General Physical Health Deterioration |
4.4% |
| Petechiae |
4.4% |
| Pruritus |
4.4% |
| Stomatitis |
4.4% |
| Urinary Tract Infection |
4.4% |
| Vomiting |
4.4% |
| Weight Decreased |
4.4% |
| Drug Interaction |
3.5% |
| Hyperkalaemia |
3.5% |
| Mucosal Inflammation |
3.5% |
| Myocardial Infarction |
3.5% |
| Suicidal Ideation |
3.5% |
| Enterocolitis |
2.7% |
| Gastrointestinal Hypermotility |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
|
